Cell death control in lymphocytes.
Newton
K
K
Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
Strasser
A
A
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D053477:Apoptotic Protease-Activating Factor 1; D001327:Autoimmune Diseases / Q000276:immunology; D020169:Caspases / Q000502:physiology; D002454:Cell Differentiation; D004195:Disease Models, Animal; D004789:Enzyme Activation; D006133:Growth Substances / Q000502:physiology; D006706:Homeostasis; D006801:Humans; D007107:Immune System / Q000166:cytology; D008214:Lymphocytes / Q000166:cytology* / Q000201:enzymology; D008221:Lymphoid Tissue / Q000166:cytology; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D008954:Models, Biological; D011506:Proteins / Q000502:physiology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D013601:T-Lymphocytes / Q000166:cytology; D014158:Transcription, Genetic
C506592:APAF1 protein, human; C506593:Apaf1 protein, mouse; D053477:Apoptotic Protease-Activating Factor 1; D006133:Growth Substances; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D018124:Receptors, Tumor Necrosis Factor; D020169:Caspases